Theleme Partners LLP MRNA Holdings History
Number of Shares
7.31 Mil
Current Holdings Value*
$303.82 Mil
% of Portfolio
20.36%
Total Estimate Gain
$404.91 Mil
% of Total Estimate Gain
39.57%
Theleme Partners LLP's Moderna Inc Holding Summary
As of 2024-12-31, Theleme Partners LLP held 7.31 Mil shares of Moderna Inc(MRNA), totaling $303.82 Mil. This investment constitutes 20.36% of their stock portfolio, and Theleme Partners LLP now holds 1.9% of the outstanding Moderna Inc(MRNA) stock.
The initial trade took place in 2019Q1. And since then Theleme Partners LLP has made 14 purchases of MRNA, at an average price of $73.84, for a total of 13.86 Mil shares. In addition, there have been 9 sales at an average price of $187.38 for 6.55 Mil shares. Based on historical transaction data and MRNA's current price of $27.46, Theleme Partners LLP's estimated gain on his MRNA holdings is $404.91 Mil, reflecting a 39.57% gain to date.
Theleme Partners LLP MRNA ($27.46) Holding Chart
Theleme Partners LLP MRNA ($27.46) Quarterly Buys and Sells
Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
---|---|---|---|---|
Shares Bought | 0 | Average Price $-/Share | ||
Shares Sold | 0 | Average Price $-/Share | ||
Current Price $0.00 | Total Estimated Gain 0 % |
Top Ranked Articles
- 1